MammaPrint® - Agendia’s Risk Of Recurrence Test

#Agendia #BluePrint #MammaPrint #BreastCancer #GenomicTest

Will my patient’s breast cancer return after surgery?

The MammaPrint® test analyzes the 70 most important genes associated with breast cancer recurrence. Results are typically available in 6 days or less, MammaPrint enables quicker, more informed decisions on pre- and post-operative treatment and can easily be integrated into diagnostic workups.

Find out more here: https://agendia.com/mammaprint/